SCHEMBL5772977

SCHEMBL5772977

COC(=O)CCc1cnoc1-c1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VEGFA P15692 1/20 0.43
FLT1 P17948 1/20 0.43
EGLN1 Q9GZT9 1/20 0.43
EGLN3 Q9H6Z9 1/20 0.43
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
TP53 P04637 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
RXRA P19793 2/20 0.41
RXRB P28702 2/20 0.41
RXRG P48443 2/20 0.41
NR4A2 P43354 1/20 0.41
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
TDO2 P48775 1/20 0.39
JAK2 O60674 1/20 0.39
CYP1A2 P05177 1/20 0.39
FFAR1 O14842 1/20 0.39
MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776177 0.88 L3MBTL1 (0.43) CCNCCDK8MEN1KMT2ARXRA
SCHEMBL5773378 0.85 CYP11B1 (0.45) EGLN1CCNCCDK8MAPTEGFR
SCHEMBL5773615 0.85 RXRA (0.56) RXRARXRBRXRGNR4A2PTPN2
SCHEMBL5773847 0.85 CCNC (0.47) CCNCCDK8MEN1KMT2ANR4A2
SCHEMBL5776699 0.84 NOTUM (0.44) CCNCCDK8TP53MEN1KMT2A
SCHEMBL5777338 0.84 CCNC (0.41) CCNCCDK8MEN1KMT2AFFAR1
SCHEMBL5775001 0.83 CCNC (0.42) CCNCCDK8MEN1KMT2AFFAR1
SCHEMBL5772543 0.83 CCNC (0.48) CCNCCDK8MEN1KMT2APTPN1
SCHEMBL5773992 0.82 CCNC (0.43) CCNCCDK8TP53MEN1KMT2A
SCHEMBL5773362 0.81 CCNC (0.41) CCNCCDK8MEN1KMT2AFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR VEGFA 2290/4885FLT1 2906/4885EGLN1 384/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 VEGFA 1912/4885FLT1 1814/4885EGLN1 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.